Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-04-25 Cantley Lewis Clayton Jr. Director Sale −627 $55.00 $34K 128,429
2016-04-25 Cantley Lewis Clayton Jr. Director Sale −625 $55.00 $34K 128,443
2016-03-30 Cantley Lewis Clayton Jr. Director Sale −627 $38.09 $24K 129,056
2016-03-30 Cantley Lewis Clayton Jr. Director Sale −625 $38.09 $24K 129,068
2016-03-29 Cantley Lewis Clayton Jr. Director Sale −627 $36.28 $23K 129,683
2016-03-29 Cantley Lewis Clayton Jr. Director Sale −625 $36.28 $23K 129,693
2016-02-26 Cantley Lewis Clayton Jr. Director Sale −627 $38.89 $24K 130,459
2016-02-26 Cantley Lewis Clayton Jr. Director Sale −625 $38.89 $24K 130,465
2016-02-25 Cantley Lewis Clayton Jr. Director Sale −627 $36.90 $23K 131,086
2016-02-25 Cantley Lewis Clayton Jr. Director Sale −625 $36.90 $23K 131,090
2016-02-16 Hoerter Steven L. Chief Commercial Officer Grant or award · Stock option (right to buy) +100,000 100,000
2016-02-16 Biller Scott Chief Scientific Officer Grant or award · Stock option (right to buy) +45,220 328,691
2016-02-16 Schenkein David P Chief Executive Officer Grant or award · Stock option (right to buy) +102,000 997,501
2016-02-16 Goddard Glenn Senior Vice President, Finance Grant or award · Stock option (right to buy) +20,330 108,572
2016-02-16 Bowden Christopher Chief Medical Officer Grant or award · Stock option (right to buy) +45,220 177,220
2016-02-03 Biller Scott Chief Scientific Officer Exercise or conversion +10,000 $0.47 $5K 59,070
2016-02-03 Biller Scott Chief Scientific Officer Exercise or conversion · Stock option (right to buy) −10,000 283,471
2016-01-29 Cantley Lewis Clayton Jr. Director Sale −627 $41.52 $26K 131,713
2016-01-29 Cantley Lewis Clayton Jr. Director Sale −625 $41.52 $26K 131,715
2016-01-28 Cantley Lewis Clayton Jr. Director Sale −627 $44.33 $28K 132,340

Page 82 of 93 · 1,853 trades